One of the main challenges in the clinical management of dengue is the early identification
of cases that could progress to severe forms of the disease. A biomarker that may enable …

Dengue is a viral infection caused by dengue virus (DENV), which has a significant impact
on public health worldwide. Although most infections are asymptomatic, a series of severe …

Population genetics theory predicted that rare frequent markers would be the main
contributors for heritability of complex diseases, but meta-analyses of genome-wide …

Introduction Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates T cell immune
responses as an immune activation inhibitor. Literature reviews suggest that COVID-19 is …

Single nucleotide polymorphisms (SNPs) in immune‐related genes have been shown to
play a role in driving the development of the severe phenotypes of dengue virus (DENV) …

Background: Torque teno virus (TTV) DNAemia has been proposed as a surrogate marker of
immunosuppression after kidney transplantation (KT), under the assumption that the control …

Dengue virus (DENV) is the causal agent of dengue fever. The symptoms and signs of
dengue vary from febrile illness to hemorrhagic syndrome. IFITM3 and TNFA are genes of …

Dengue is a global and growing health threat, especially in Southeast Asia, West Pacific and
South America. Infection by the dengue virus (DENV) results in dengue fever, which can …

Background Dengue patients develop different disease severity ranging from mild (dengue
fever [DF]) to severe forms (dengue hemorrhagic fever [DHF] and the fatal dengue shock …